Published in Contrib Nephrol on June 09, 2011
Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One (2012) 1.31
Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol (2013) 0.98
Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea. Diabetes Metab J (2015) 0.95
Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice. PLoS One (2014) 0.94
Suramin: a potential therapy for diabetic nephropathy. PLoS One (2013) 0.86
Ultrasound-targeted stromal cell-derived factor-1-loaded microbubble destruction promotes mesenchymal stem cell homing to kidneys in diabetic nephropathy rats. Int J Nanomedicine (2014) 0.85
Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev (2013) 0.83
Reactive Oxygen Species and Nuclear Factor Erythroid 2-Related Factor 2 Activation in Diabetic Nephropathy: A Hidden Target. J Diabetes Metab (2015) 0.79
Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1. Exp Ther Med (2012) 0.79
Alpha Lipoic Acid Modulated High Glucose-Induced Rat Mesangial Cell Dysfunction via mTOR/p70S6K/4E-BP1 Pathway. Int J Endocrinol (2014) 0.78
Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats. J Diabetes Res (2015) 0.78
Text mining of the classical medical literature for medicines that show potential in diabetic nephropathy. Evid Based Complement Alternat Med (2014) 0.78
Transcriptomic analysis in diabetic nephropathy of streptozotocin-induced diabetic rats. Int J Mol Sci (2011) 0.77
Elevated serum levels of mannose-binding lectin and diabetic nephropathy in type 2 diabetes. PLoS One (2015) 0.77
Rodent animal models: from mild to advanced stages of diabetic nephropathy. Inflammopharmacology (2014) 0.77
Fluctuation between fasting and 2-H postload glucose state is associated with glomerular hyperfiltration in newly diagnosed diabetes patients with HbA1c < 7%. PLoS One (2014) 0.76
Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy. Cureus (2015) 0.76
Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease. BMC Complement Altern Med (2016) 0.76
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data? J Clin Med (2015) 0.76
Over-expression of muscle glycogen synthase in human diabetic nephropathy. Histochem Cell Biol (2014) 0.76
Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic Review. Evid Based Complement Alternat Med (2013) 0.75
Low ankle-brachial index is associated with early-stage chronic kidney disease in type 2 diabetic patients independent of albuminuria. PLoS One (2014) 0.75
Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice. PLoS One (2016) 0.75
Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy. Histochem Cell Biol (2017) 0.75
Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression. Sci Rep (2017) 0.75
Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy. Drug Des Devel Ther (2017) 0.75
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int (2004) 2.29
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol (2005) 2.23
Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.66
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant (2004) 1.42
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant (2009) 1.14
A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol (2007) 1.13
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12
Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust (2008) 1.11
Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol (2003) 1.08
Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection? Nephrology (Carlton) (2007) 1.04
Arterial function after successful renal transplantation. Kidney Int (2004) 1.04
Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis (2004) 1.03
Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol (2004) 1.00
Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial. Nephrol Dial Transplant (2006) 1.00
The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring) (2007) 0.99
Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int (2003) 0.99
A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int (2007) 0.98
Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs (2006) 0.97
Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol (2002) 0.97
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol (2002) 0.97
Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int (2003) 0.96
Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant (2003) 0.96
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int (2003) 0.95
p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol (2004) 0.95
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol (2005) 0.95
Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant (2003) 0.92
Diabetic kidney disease: act now or pay later. Acta Diabetol (2010) 0.90
Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J Am Soc Nephrol (2004) 0.89
Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol (2003) 0.89
Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am J Kidney Dis (2006) 0.89
Television viewing time and risk of chronic kidney disease in adults: the AusDiab Study. Ann Behav Med (2010) 0.88
Laboratory assessment of immune function in renal transplant patients. Nephrol Dial Transplant (2003) 0.88
A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Kidney Int Suppl (2005) 0.87
Renal processing of serum proteins in an albumin-deficient environment: an in vivo study of glomerulonephritis in the Nagase analbuminaemic rat. Nephrol Dial Transplant (2004) 0.87
Vascular access practice patterns in the New Zealand hemodialysis population. Am J Kidney Dis (2004) 0.87
Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis (2013) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation (2002) 0.86
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial. Kidney Int Suppl (2004) 0.85
Physical inactivity and chronic kidney disease in Australian adults: the AusDiab study. Nutr Metab Cardiovasc Dis (2009) 0.85
Diabetes: Diabetic kidney disease: act now or pay later. Nat Rev Nephrol (2010) 0.84
Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab study. J Hypertens (2011) 0.84
Leukocyte phenotype and function predicts infection risk in renal transplant recipients. Nephrol Dial Transplant (2005) 0.83
Epidemiology of vascular access in the Australian hemodialysis population. Kidney Int (2003) 0.83
Diabetic kidney disease: act now or pay later. J Am Soc Hypertens (2010) 0.81
Diabetic kidney disease: act now or pay later. Kidney Int (2010) 0.81
Predictive value of nephelometric and high-performance liquid chromatography assays of urine albumin for mortality in a high-risk Aboriginal population. Am J Kidney Dis (2008) 0.80
Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. Am J Kidney Dis (2009) 0.80
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001. Nephrology (Carlton) (2003) 0.80
Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers. Nephrology (Carlton) (2013) 0.80
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells. Nephrology (Carlton) (2003) 0.80
Diabetic kidney disease: act now or pay later. J Bras Nefrol (2010) 0.79
Low-carb, low-fat diet gurus face off. Interview by Joan Stephenson. JAMA (2003) 0.79
Dissecting the diets. Newsweek (2003) 0.79
Waist circumference has heterogeneous impact on development of diabetes in different populations: longitudinal comparative study between Australia and Iran. Diabetes Res Clin Pract (2010) 0.79
Extracellular signal-regulated kinase-dependent interstitial macrophage proliferation in the obstructed mouse kidney. Nephrology (Carlton) (2008) 0.78
Diabetic kidney disease: act now or pay later--World Kidney Day, 11 March 2010: we must act on diabetic kidney disease. Ther Apher Dial (2010) 0.77
Role of interleukin-10 in rat mesangioproliferative glomerulonephritis. Nephrology (Carlton) (2003) 0.77
Macrophage accumulation and renal fibrosis are independent of macrophage migration inhibitory factor in mouse obstructive nephropathy. Nephrology (Carlton) (2004) 0.77
Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy. Nephron Clin Pract (2011) 0.77
Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency. Nephrology (Carlton) (2005) 0.77
Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection. Am J Transplant (2003) 0.76
Reproducibility of urinary albumin assays by immunonephelometry after long-term storage at -70°C. Am J Kidney Dis (2011) 0.76
Albumin and glomerular permselectivity. Nephrol Dial Transplant (2004) 0.75
Albuminuria and renal insufficiency prevalence guides population screening. Kidney Int (2003) 0.75
Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment. Transpl Immunol (2004) 0.75
HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol (2007) 0.75
Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantation. Nephrology (Carlton) (2003) 0.75
What have we learned from clinical trials on prevention? Kidney Int Suppl (2005) 0.75
Lei-Shi Li: a giant in international nephrology. Kidney Int (2010) 0.75
The role of flow cytometric ANCA detection in screening for acute pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant (2004) 0.75
Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement. Am J Hematol (2004) 0.75
Diabetic kidney disease: act now or pay later. Acta Physiol Hung (2010) 0.75
Acute neuromuscular weakness in a boy with a facial abscess contaminated with Clostridium botulinum. Pediatr Infect Dis J (2012) 0.75
Diabetic kidney disease: act now or pay later. Clin Nephrol (2010) 0.75
Diabetic kidney disease: act now or pay later. Pediatr Nephrol (2009) 0.75
Diabetic kidney disease: act now or pay later. Nephrology (Carlton) (2010) 0.75
Diabetic kidney disease: act now or pay later. Arch Iran Med (2010) 0.75
Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporin. ANZ J Surg (2002) 0.75